pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,970 catalysts · 5,347 phase readout · 2,277 8k filing · 343 pdufa · 257 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 18 catalysts2026-08-06: 11 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 2 catalysts2026-08-11: 1 catalyst2026-08-12: 2 catalysts2026-08-13: 1 catalyst2026-08-14: 1 catalyst2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 0 catalysts2026-10-27: 2 catalysts2026-10-28: 1 catalyst2026-10-29: 3 catalysts2026-10-30: 0 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,347
  • 8k filing2,277
  • pdufa343
  • earnings257
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›ACTIVE_NOT_RECRUITINGphase readoutNCT02354079: HYPOCHOL : A Genetically-based Strategy to Identify New Targets in Cholesterol Metabolism

Sponsor: Nantes University Hospital. Phase: NA. Conditions: Hypobetalipoproteinemia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05397496: Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies

Sponsor: Novartis Pharmaceuticals. Phase: PHASE1. Conditions: B-cell Non-Hodgkin Lymphoma (B-NHL), B-cell Acute Lymphoblastic Leukemia (B-ALL)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06217588: LCAT (Lecithin Cholesterol Acyl Transferase) Natural History Study

Sponsor: University of Pennsylvania. Phase: . Conditions: LCAT Deficiency

full page →ctgov ↗
›COMPLETEDphase readoutNCT07379788: ARNI Combined With SGLT2 Inhibitors on Functional Mitral Regurgitation Remodeling

Sponsor: Rehab Werida. Phase: . Conditions: Heart Failure

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07550803: Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery

Sponsor: Seoul National University Hospital. Phase: NA. Conditions: Sleep Disturbance

full page →ctgov ↗
›SUSPENDEDphase readoutNCT05200442: A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer

Sponsor: University of Chicago. Phase: PHASE1. Conditions: Colorectal Cancer, Colorectal Adenocarcinoma, Colorectal Cancer Metastatic, Advanced Colorectal Carcinoma, Advanced Colorectal Adenocarcinoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07427186: Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy of Immunotherapy in Patients With Early Stage Cancer

Sponsor: Institut Claudius Regaud. Phase: NA. Conditions: Solid Cancers

full page →ctgov ↗
›COMPLETEDphase readoutNCT07406386: Integrating Halotherapy Into Preseason Training Improves Respiratory and Aerobic Performance in Elite Female Soccer Players

Sponsor: Gümüşhane Universıty. Phase: NA. Conditions: Aerobic Performance, Respiratory Function, Athletic Performance, Respiratory Muscle Strength, Elite Female Athletes, Halotherapy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07366086: Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta

Sponsor: Amgen. Phase: PHASE3. Conditions: Osteogenesis Imperfecta

full page →ctgov ↗
›COMPLETEDphase readoutNCT07334886: A Study of [14C]Ulonivirine ([14C]MK-8507) in Healthy Adults (MK-8507-006)

Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE1. Conditions: Healthy

full page →ctgov ↗
›COMPLETEDphase readoutNCT07571070: High-Intensity Intermittent Training and Sport-Specific Performance in Youth Amateur Boxers

Sponsor: Federal University of Vicosa. Phase: NA. Conditions: Athletic Performance, Exercise Training, Physical Fitness

full page →ctgov ↗
›RECRUITINGphase readoutNCT07457970: Community Health Worker Coaching to Reduce Cardiovascular Risk Among Women After a Hypertensive Disorder of Pregnancy

Sponsor: University of South Carolina. Phase: NA. Conditions: Blood Pressure Monitoring, Hypertension (HTN), Pregnancy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07541469: Rezdiffra Pregnancy and Lactation Registry

Sponsor: Madrigal Pharmaceuticals, Inc.. Phase: . Conditions: MASH - Metabolic Dysfunction-Associated Steatohepatitis

full page →ctgov ↗
›COMPLETEDphase readoutNCT07381283: Immediate Versus Delayed Loading of Dental Implants in the Anterior Maxilla

Sponsor: Suez Canal University. Phase: NA. Conditions: Partial Edentulism of the Maxilla, Dental Implant Loading, Tooth Loss in the Anterior Maxilla

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05335941: A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial Carcinoma

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Urothelial Carcinoma, Metastatic Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06893341: Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events

Sponsor: Indiana University. Phase: NA. Conditions: Diabetes, Hyperglycemia, Hypoglycemia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07521241: A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults

Sponsor: Addpharma Inc.. Phase: PHASE1. Conditions: Chronic Liver Disease (CLD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT01143454: Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: . Conditions: Metabolic Disease, Obesity, Li-Fraumeni Syndrome, Cardiomyopathy, Atherosclerosis, Inflammatory Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT06243354: Phase 1/2 Study of HYP-2090PTSA in Patients With Advanced Solid Tumors Harboring KRAS Mutation

Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd. Phase: PHASE1. Conditions: Safety, Tolerability, Efficacy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05408494: Engaging Men in Weight Loss With a Game-based mHealth and Neurotraining Program

Sponsor: Drexel University. Phase: NA. Conditions: Obesity, Weight Loss

full page →ctgov ↗
›COMPLETEDphase readoutNCT07366294: Lemongrass (Cymbopogon Citratus) on Nicotine Dependence, Cotinine Levels, and Related Biomarkers in Adult Smokers

Sponsor: Titin Andri Wihastuti. Phase: NA. Conditions: Nicotine Dependence, Cigarette Smoking, Tobacco Use Disorder, Psychological Stress, Sleep Disturbance

full page →ctgov ↗
›RECRUITINGphase readoutNCT07381894: Multicentre Hypertrophic Cardiomyopathy Registry

Sponsor: University of Manchester. Phase: . Conditions: Hypertrophic Cardiomyopathy (HCM)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06738966: A Study of BL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic Cancer

Sponsor: Shanghai Best-Link Bioscience, LLC. Phase: PHASE1. Conditions: Breast Cancer, Ovarian Cancer, Endometrial Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07070466: Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

Sponsor: Massachusetts General Hospital. Phase: PHASE2. Conditions: Stomach Cancer Stage IV, Esophagus Cancer, Stomach Cancer

full page →ctgov ↗
›SUSPENDEDphase readoutNCT05977556: Perioperative Prehabilitation on Markers of Fitness and Frailty in Patients Undergoing Elective Surgery

Sponsor: University of Alberta. Phase: PHASE1. Conditions: Frailty

full page →ctgov ↗
›COMPLETEDphase readoutNCT03776656: Evaluation of a Treatment With Allopurinol in Adenylosuccinate Lyase Deficiency

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE2. Conditions: Adenylosuccinate Lyase Deficiency

full page →ctgov ↗
›RECRUITINGphase readoutNCT05925322: Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality

Sponsor: Weill Medical College of Cornell University. Phase: NA. Conditions: Depression, Suicidal Ideation, Major Depressive Disorder, Depressive Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT05399329: Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan

Sponsor: Pfizer. Phase: . Conditions: Breast Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05934929: Contribution of Residual Tumour DNA Testing on the Surgical Bed

Sponsor: Centre Henri Becquerel. Phase: NA. Conditions: Squamous Cell Carcinoma of the Oral Cavity

full page →ctgov ↗
›COMPLETEDphase readoutNCT06426329: The Effect of Therapeutic Touch at Birth on Pain, Birth Duration, Traumatic Birth Perception and Anxiety

Sponsor: Cumhuriyet University. Phase: NA. Conditions: Pregnancy, Vaginal Delivery

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06141031: Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

Sponsor: Washington University School of Medicine. Phase: PHASE1. Conditions: Pancreatic Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06789653: A Novel Approach Utilizing Organ Specific Age Proteomics

Sponsor: UNC Lineberger Comprehensive Cancer Center. Phase: . Conditions: Breast Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07564297: North American Fetal Therapy Network Prospective Registry for Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia

Sponsor: Mayo Clinic. Phase: . Conditions: Congenital Diaphragmatic Hernia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06993610: Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense

Sponsor: Zura Bio Inc. Phase: PHASE2. Conditions: Hidradenitis Suppurativa (HS)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07436182: Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. Metformin Monotherapy

Sponsor: Mansoura University. Phase: PHASE4. Conditions: Mitochondria, Metformin

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07437482: Cancer Literacy Education and Awareness Resources for Prostate Care

Sponsor: Universidad Miguel Hernandez de Elche. Phase: . Conditions: Health Literacy, Prostate Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT04899024: PrEP Affect Regulation Treatment Innovation

Sponsor: Florida International University. Phase: NA. Conditions: Medication Adherence, HIV Prevention, Stimulant Use

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07554924: A Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type I

Sponsor: Lanyue Biotech (Hangzhou) Co., Ltd.. Phase: PHASE1. Conditions: Spinal Muscular Atrophy 1

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07560124: A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Breast Cancer

Sponsor: Akeso. Phase: PHASE1. Conditions: Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07136688: Tibial Nerve Stimulation for Pediatric Spina Bifida Neurogenic Bladder

Sponsor: The University of Texas Health Science Center, Houston. Phase: NA. Conditions: Neurogenic Bladder Due to Spina Bifida

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07566442: Frenkel Exercises on Balance and Quality of Life Post Burns

Sponsor: Cairo University. Phase: NA. Conditions: Burns, Lower Limb Burn Injury

full page →ctgov ↗
›RECRUITINGphase readoutNCT06597942: Deep Repetitive Transcranial Magnetic Stimulation (rTMS) of the Precuneus for Alzheimer Disease (AD)

Sponsor: University of California, Los Angeles. Phase: PHASE1. Conditions: Alzheimer&Amp;Amp;#39;s Disease, Alzheimer Disease, Dementia Alzheimer Type, Mild Alzheimer&Amp;Amp;#39;s Disease, Moderate Alzheimer&Amp;Amp;#39;s Disease, Alzheimer&Amp;#39;s Disease (AD), Alzheimer&Amp;#39;s Dementia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07561242: Clinical Observational Study on Changes in Skin Physiological Parameters Following Ablative and Non-Ablative Fractional Laser Treatment at Different Doses

Sponsor: ChinaNorm. Phase: . Conditions: Skin Barrier Function, Wound Healing

full page →ctgov ↗
›RECRUITINGphase readoutNCT06124586: Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)

Sponsor: Heinrich-Heine University, Duesseldorf. Phase: NA. Conditions: Diabetic Foot, Diabetes Mellitus, Peripheral Arterial Disease, Diabetic Neuropathies, Diabetic Retinopathy, Anemia, Ulcer Foot, Ulcer Ischemic, Diabetic Polyneuropathy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05297786: Hemodialysis.-Induced Hypotension Therapy for End Stage Kidney Disease

Sponsor: Vanderbilt University Medical Center. Phase: PHASE2. Conditions: Hemodialysis Complication, Hypotension of Hemodialysis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07340073: Coordinated Reset Deep Brain Stimulation for Parkinson's Disease

Sponsor: University of Minnesota. Phase: PHASE1. Conditions: Parkinson's Disease (PD), Deep Brain Stimulation

full page →ctgov ↗
›COMPLETEDphase readoutNCT06396741: Changes in the Quadriceps Muscle After Dry Needling Treatment

Sponsor: Prof. Dr. Daniel Pecos Martín. Phase: NA. Conditions: Muscle Tightness, Muscle Strain

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07220954: A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234

Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Healthy Participants

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07479654: AI-Enabled Frailty Risk Prediction in Adult Congenital Heart Disease

Sponsor: Mackay Memorial Hospital. Phase: NA. Conditions: Adult Congenital Heart Disease, Symptom Clusters, Frailty, Risk Prediction Model, Artificial Intelligence-Based Voice Emotion Detection

full page →ctgov ↗
›RECRUITINGphase readoutNCT06866405: A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose

Sponsor: Pfizer. Phase: PHASE3. Conditions: RSV Infection

full page →ctgov ↗
← prev
page 78 of 160
next →